The health subcommittee of the House Energy and Commerce (E&C) Committee will hold a markup this week of the proposed Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization – now known as the Preparing for All Hazards and Pathogens Reauthorization Act. But the markup comes with a key catch for the FDA: Essentially none of its legislative requests will be met.
Quick background: the Pandemic and All-Hazards Preparedness Act
The Pandemic and All-Hazards Preparedness Act (PAHPA) was originally passed in 2006.
Fill out the form to read the full article.
